China extends timeline for revised reimbursement list

China's National Medical Insurance Administration has pushed out its timeline for a revised National Drug Reimbursement List by at least a month, according to a finalized plan

Read the full 275 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE